BR9708103A - Compound or a pharmaceutically acceptable derivative and process for preparing it - Google Patents

Compound or a pharmaceutically acceptable derivative and process for preparing it

Info

Publication number: BR9708103A
Authority: BR; Brazil
Prior art keywords: preparing; compound; pharmaceutically acceptable; acceptable derivative; derivative
Prior art date: 1996-03-20

Application number

BR9708103A

Other languages

Portuguese (pt)

Inventor

John Bantick

Roger Victor Bonnert

Peter Alan Cage

David Donald

Mark Furber

Simon Hirst

Matthew Perry

Eifion Phillips

Original Assignee

Astra Pharma Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-20

Filing date

1997-03-20

Publication date

1999-07-27

1996-03-20 Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en

1996-05-18 Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en

1996-05-24 Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en

1997-01-16 Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en

1997-03-20 Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod

1999-07-27 Publication of BR9708103A publication Critical patent/BR9708103A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

BR9708103A 1996-03-20 1997-03-20 Compound or a pharmaceutically acceptable derivative and process for preparing it BR9708103A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9605803.7A GB9605803D0 (en)	1996-03-20	1996-03-20	Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en)	1996-05-18	1996-05-18	Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en)	1996-05-24	1996-05-24	Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en)	1997-01-16	1997-01-16	Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (en)	1996-03-20	1997-03-20	Pharmaceutically useful compounds

Publications (1)

Publication Number	Publication Date
BR9708103A true BR9708103A (en)	1999-07-27

Family

ID=27451427

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9708103A BR9708103A (en)	1996-03-20	1997-03-20	Compound or a pharmaceutically acceptable derivative and process for preparing it

Country Status (19)

Country	Link
EP (1)	EP0888347A1 (en)
JP (1)	JP2000506884A (en)
KR (1)	KR20000064716A (en)
CN (1)	CN1218472A (en)
AR (1)	AR006520A1 (en)
AU (1)	AU712141B2 (en)
BR (1)	BR9708103A (en)
CA (1)	CA2247814A1 (en)
CZ (1)	CZ297798A3 (en)
EE (1)	EE9800298A (en)
ID (1)	ID16283A (en)
IL (1)	IL126271A0 (en)
IS (1)	IS4848A (en)
NO (1)	NO984290L (en)
NZ (1)	NZ331614A (en)
PL (1)	PL328921A1 (en)
SK (1)	SK118798A3 (en)
TR (1)	TR199801861T2 (en)
WO (1)	WO1997034893A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10110749A1 (en) *	2001-03-07	2002-09-12	Bayer Ag	Substituted aminodicarboxylic acid derivatives
JP2003002863A (en) *	2001-06-25	2003-01-08	Nippon Soda Co Ltd	Method for producing benzoic acids and novel compounds
US6642249B2 (en)	2001-07-04	2003-11-04	Active Biotech Ab	Immunomodulating compounds
SE0102404D0 (en) *	2001-07-04	2001-07-04	Active Biotech Ab	Novel immunomodulating compounds
DE10229762A1 (en) *	2002-07-03	2004-01-22	Aventis Pharma Deutschland Gmbh	Pyrazoloisoquinoline derivatives for the inhibition of NFkappaB-inducing kinase
US7081456B2 (en) *	2002-11-22	2006-07-25	Active Biotech Ab	Immunomodulatory compounds
AU2003287129A1 (en)	2002-12-16	2004-07-09	Active Biotech Ab	Tetracyclic immunomodulatory compounds
EA014080B1 (en)	2003-03-14	2010-08-30	Медиджен Лимитед	Immunomodulating heterocyclic compounds
GB0325644D0 (en)	2003-11-04	2003-12-10	Avidex Ltd	Immuno ihibitory pyrazolone compounds
RU2006124843A (en)	2003-12-12	2008-01-20	Уайт (Us)	QUINOLINS SUITABLE FOR TREATMENT OF CARDIOVASCULAR DISEASE
FR2870239B1 (en) *	2004-05-11	2006-06-16	Sanofi Synthelabo	DERIVATIVES OF 2H- OR 3H-BENZO [E] INDAZOL-1-YLE CARBAMATE, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
GB0411770D0 (en) *	2004-05-26	2004-06-30	Avidex Ltd	Immuno inhibitory heterocyclic compouds
US7932253B2 (en)	2004-08-09	2011-04-26	Medigene Ag	Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
AP2527A (en)	2006-10-31	2012-12-06	Pfizer Prod Inc	Pyrazoline compounds as mineralocorticoid receptorantagonists
CN102372710A (en)	2010-08-18	2012-03-14	山东轩竹医药科技有限公司	Fused cyclic compound being taken as mineral corticoid recept antagonist
WO2012108511A1 (en)	2011-02-09	2012-08-16	日産化学工業株式会社	Pyrazole derivative and pest control agent
EP3846904B1 (en) *	2018-09-07	2023-05-31	Merck Patent GmbH	5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
US11753413B2 (en)	2020-06-19	2023-09-12	Incyte Corporation	Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
WO2021257857A1 (en)	2020-06-19	2021-12-23	Incyte Corporation	Naphthyridinone compounds as jak2 v617f inhibitors
AU2021300429A1 (en)	2020-07-02	2023-02-16	Incyte Corporation	Tricyclic urea compounds as JAK2 V617F inhibitors
WO2022006456A1 (en)	2020-07-02	2022-01-06	Incyte Corporation	Tricyclic pyridone compounds as jak2 v617f inhibitors
WO2022046989A1 (en)	2020-08-27	2022-03-03	Incyte Corporation	Tricyclic urea compounds as jak2 v617f inhibitors
WO2022140231A1 (en)	2020-12-21	2022-06-30	Incyte Corporation	Deazaguaine compounds as jak2 v617f inhibitors
WO2022182839A1 (en)	2021-02-25	2022-09-01	Incyte Corporation	Spirocyclic lactams as jak2 v617f inhibitors
CN119173514A (en)	2022-03-17	2024-12-20	因赛特公司	Tricyclic urea compounds as JAK2 V617F inhibitors
CN119638634B (en) *	2023-09-18	2026-01-30	上海赛默罗生物科技有限公司	2-oxo-coral compounds, their preparation methods and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4524146A (en) *	1982-12-08	1985-06-18	Ciba-Geigy Corporation	Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (en) *	1984-11-05	1986-05-30	Shionogi & Co Ltd	Thienylpyrazoloquinoline derivative
SE8903564D0 (en) *	1989-10-26	1989-10-26	Pharmacia Ab	NEW USE CONDENSED QUINOLINE COMPOUND
JPH05194515A (en) *	1991-07-31	1993-08-03	Kyowa Hakko Kogyo Co Ltd	Condensed naphthyridine derivative

1997
- 1997-03-19 ID IDP970892A patent/ID16283A/en unknown
- 1997-03-19 AR ARP970101094A patent/AR006520A1/en unknown
- 1997-03-20 AU AU21867/97A patent/AU712141B2/en not_active Ceased
- 1997-03-20 IL IL12627197A patent/IL126271A0/en unknown
- 1997-03-20 KR KR1019980707441A patent/KR20000064716A/en not_active Withdrawn
- 1997-03-20 CZ CZ982977A patent/CZ297798A3/en unknown
- 1997-03-20 EE EE9800298A patent/EE9800298A/en unknown
- 1997-03-20 WO PCT/SE1997/000471 patent/WO1997034893A1/en not_active Ceased
- 1997-03-20 BR BR9708103A patent/BR9708103A/en unknown
- 1997-03-20 CN CN97194665A patent/CN1218472A/en active Pending
- 1997-03-20 EP EP97914729A patent/EP0888347A1/en not_active Withdrawn
- 1997-03-20 CA CA002247814A patent/CA2247814A1/en not_active Abandoned
- 1997-03-20 PL PL97328921A patent/PL328921A1/en unknown
- 1997-03-20 TR TR1998/01861T patent/TR199801861T2/en unknown
- 1997-03-20 NZ NZ331614A patent/NZ331614A/en unknown
- 1997-03-20 SK SK1187-98A patent/SK118798A3/en unknown
- 1997-03-20 JP JP9533412A patent/JP2000506884A/en active Pending
1998
- 1998-09-16 NO NO984290A patent/NO984290L/en unknown
- 1998-09-16 IS IS4848A patent/IS4848A/en unknown

Also Published As

Publication number	Publication date
CA2247814A1 (en)	1997-09-25
NO984290L (en)	1998-10-27
ID16283A (en)	1997-09-18
EP0888347A1 (en)	1999-01-07
EE9800298A (en)	1999-02-15
CZ297798A3 (en)	1999-03-17
AR006520A1 (en)	1999-09-08
NZ331614A (en)	2000-07-28
AU2186797A (en)	1997-10-10
IL126271A0 (en)	1999-05-09
JP2000506884A (en)	2000-06-06
AU712141B2 (en)	1999-10-28
PL328921A1 (en)	1999-03-01
NO984290D0 (en)	1998-09-16
CN1218472A (en)	1999-06-02
IS4848A (en)	1998-09-16
SK118798A3 (en)	1999-03-12
TR199801861T2 (en)	1998-12-21
KR20000064716A (en)	2000-11-06
WO1997034893A1 (en)	1997-09-25

Publication	Publication Date	Title
BR9708103A (en)	1999-07-27	Compound or a pharmaceutically acceptable derivative and process for preparing it
PT850948E (en)	2002-08-30	PROPIONPHENONE DERIVATIVES AND PROCESS FOR THE PREPARATION OF THE SAME
BR9707251A (en)	1999-04-06	Process compounds for their preparation and pharmaceutical compositions
BR9407306A (en)	1996-10-08	Pharmaceutical composition for oral administration and process for preparing the same
BR9711340A (en)	1999-08-17	Compound pharmaceutical composition and process for preparing a compound
PT873308E (en)	2002-06-28	O-CARBAMOYL-PHENYL-ANANINOL COMPOUNDS AND THEIR PREPARATION OF THE PHARMACEUTICALLY USEFUL SALTS AND PROCESS FOR THE PREPARATION OF THE SAME
BR9711201A (en)	1999-08-17	Process for the preparation of a compound
BR9707811A (en)	1999-07-27	Process for preparing a compound and compound
PT909270E (en)	2002-11-29	METHOD FOR THE PREPARATION OF 2,4-DIHYDROXYPRIDINE AND 2,4-DIHIDROXY-3-NITROPYRIDINE
BR9703467A (en)	1998-10-06	Process for the preparation of diketopyrrolopyrrole derivatives
BR9305161A (en)	1994-11-01	Compound, pharmaceutical composition and process for preparing the compound
PT839138E (en)	2004-10-29	PROCESS FOR THE PREPARATION OF N-SUBSTITUTED 3-HYDROXYPRAZOES
BR9708763A (en)	1999-08-03	[2- (1-piperazinyl) -ethoxy] -methyl substituted process for preparing the same and compound and using the same
BR9608374A (en)	1999-08-24	Process for the preparation of lercanidipine hydrochloride
BR9601294A (en)	1998-01-13	Compound and process for preparing it
PT877738E (en)	2003-09-30	PROCESS FOR THE PREPARATION OF PHENYL-IMIDAZOLIDINE DERIVATIVES
BR9611792A (en)	1999-07-13	Activated catalyst composition and process for preparing the same
PT1028960E (en)	2003-09-30	METHOD FOR THE PREPARATION OF THIAZOLIDINODIONA DERIVATIVES
PT923599E (en)	2002-06-28	METHOD FOR THE PREPARATION OF 17-ESTERS OF 9ALFA, 21-DI-HALOPREGENE-11BETA, 17ALFADIOL-20-ONES
BR9608120A (en)	1999-02-09	Pharmaceutical composition and process for preparing it
BR9707173A (en)	1999-04-06	Process for the preparation of a compound and compound
PT803576E (en)	2003-03-31	PROCESS FOR THE PREPARATION OF LIPSTATIN AND TETRAHYDROLYSTATIN
BR9711131A (en)	1999-08-17	Process for preparing a compound and compounds
BR9711994A (en)	1999-08-24	Beta-lactam compounds and the process for preparing them
BR9604796A (en)	1998-07-07	Compound and process for preparing a compound

Legal Events

Date	Code	Title	Description
2004-12-21	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]